Wall Street Today: Trump Assigns Tariff Homework Study, Market Climbs

Kevin TraversFeb 13 16:20 ET

Incyte Jumps Amid Takeover Speculation

Seeking AlphaFeb 13 15:03 ET

Express News | Watching Incyte Shares, Hearing M&A Blog Mentions Merck As Potential Buyer

BenzingaFeb 13 14:49 ET

Live Stock News: Tariffs are so Back While Stocks Climb

Kevin TraversFeb 13 11:27 ET

Incyte Corporation's (NASDAQ:INCY) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall StFeb 13 06:50 ET

Incyte's Strong Q4 Performance and Promising Growth Outlook Earns 'Buy' Rating

TipRanksFeb 13 00:42 ET · Ratings

Incyte Corp. Stock Climbs 4.1%, Outperforms Competitors

Dow JonesFeb 12 16:42 ET

Wall Street Today: Give Jerome More Time, He Says He's Got This

Kevin TraversFeb 12 16:41 ET

J.P. Morgan Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $70

Moomoo NewsFeb 12 14:31 ET · Ratings

Live Stock News: Inflation Climbing, Powell Testifying, and Trump Accommodating Toddlers in Oval Office

Kevin TraversFeb 12 10:56 ET

JPMorgan Adjusts Incyte Price Target to $70 From $75, Maintains Neutral Rating

MT NewswiresFeb 12 10:27 ET · Ratings

UBS Maintains Incyte(INCY.US) With Hold Rating, Cuts Target Price to $69

Moomoo NewsFeb 12 05:32 ET · Ratings

Incyte's Earnings Call: Robust Growth Amid Challenges

TipRanksFeb 11 19:19 ET

Wall Street Today: Market Mostly Sideways After Senate Testimony

Kevin TraversFeb 11 16:18 ET

Live Stock News: Powell Said no Time Like the Present to do Nothing

Kevin TraversFeb 11 11:48 ET

Express News | JMP Securities Reiterates Market Perform on Incyteto Market Perform

BenzingaFeb 11 10:58 ET

Jefferies Maintains Incyte(INCY.US) With Buy Rating, Cuts Target Price to $81

Moomoo NewsFeb 11 09:31 ET · Ratings

TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $88

Moomoo NewsFeb 11 09:31 ET · Ratings

Truist Financial Maintains Incyte(INCY.US) With Hold Rating

Moomoo NewsFeb 11 09:31 ET · Ratings

RBC Capital Maintains Sector Perform on Incyte, Lowers Price Target to $68

BenzingaFeb 11 09:05 ET · Ratings